In this narrative review of studies evaluating antiretroviral stewardship programs (ARVSPs), we propose core elements for ARVSPs that are based on published evidence, clinical experience, and adapted from antimicrobial stewardship programs.
Treatment with a combination of tenofovir and pegylated interferon yielded higher rates of hepatitis B surface antigen (HBsAg) loss than when either drug was used singly. Further, with longer therapy duration improved results.
Researchers have found that individuals with cytomegalovirus retinitis have a more advanced HIV infection than individuals with ocular syphilis.
Pharmacists can play an important role in managing the use of these medications in patients, particularly those with high blood pressure.
A death from an antibiotic-resistant infection occurs about every 15 minutes in the United States. The CDC’s 2019 threat report dives into national infection estimates and actions we can take to combat this threat.
Researchers safely infuse engineered immune cells in groundbreaking gene therapy study.
Evidence is accumulating that influenza vaccination protection wanes over the course of a single influenza season, with significant implications for public health.
Investigators from the University of California San Diego Medical School report on the first case of Gardnerella bacteremia in an HIV-positive male following the placement of a urinary catheter.
A new trial conducted in England has discovered a cost-effective way to reduce the overprescribing of antibiotics by general practitioners (GPs).
Moving away from the standard course of IV antibiotics.
How has treating infections changed with the availability of experimental vaccines and therapeutics, and how can we apply this to COVID-19 today?
A full case study from our August 2020 issue.
A patient with HIV and skin lesions should trigger a broad differential.
We review current and emerging treatment options for infections caused by the difficult-to-treat, intrinsically multidrug-resistant organism Stenotrophomonas maltophilia.
Being immunocompromised increases risk of rare Mycobacterium tuberculosis epididymo-orchitis.
Antibiotics are the mainstay treatment for CAP; however, the additive role of corticosteroids is continually being debated.
Expanding the differential for diarrhea beyond Clostridium difficile.
SMUCLA implements high-touch wipe down intervention to address the need for environmental disinfection of cancer patient care areas.
A commentary on β-lactam combination therapy for methicillin-resistant Staphylococcus aureus bacteremia.
While rising temperatures and sea levels are often considered, changing climate patterns can have vast implications for epidemic risk as well.
A death from an antibiotic-resistant infection occurs about every 15 minutes in the United States. The CDC’s 2019 threat report dives into national infection estimates and actions we can take to combat this threat.
Outcomes in disseminated nocardiosis are variable and depend on patient factors.
New public health perspectives on aspergillosis, sporotrichosis, histoplasmosis, and coccidioidomycosis.
A review of the current literature and future directions.
It can help inform appropriate antibiotic prescribing, but likely would only form part of testing protocol, experts say.
With advancements in antiretroviral therapy, people with HIV are now living longer and developing age-related chronic conditions.
A patient with HIV and skin lesions should trigger a broad differential.
Rising incidence of viral and bacterial infections has accompanied the opioid crisis, but it also presents new opportunities for multidisciplinary treatment and preventive care.